4.4 Article

Alanyl-tRNA Synthetase 2 (AARS2)-Related Ataxia Without Leukoencephalopathy

Journal

CEREBELLUM
Volume 19, Issue 1, Pages 154-160

Publisher

SPRINGER
DOI: 10.1007/s12311-019-01080-y

Keywords

AARS2; Cerebellar ataxia; Ovarioleukodystrophy; Leukoencephalopathy; Recessive ataxia

Categories

Funding

  1. NIH Medical Scientist Training Program [GM007863]
  2. NIH Cellular and Molecular Biology Training Grant [GM007315]
  3. NIH National Research Service Award (F31) from the National Institute of Neurological Disorders and Stroke [NS113515]
  4. National Institute of General Medical Sciences [GM118647]
  5. NINDS [NS085054]

Ask authors/readers for more resources

Mutations in the mitochondrial alanyl-tRNA synthetase gene, AARS2, have been reported to cause leukoencephalopathy associated with early ovarian failure, a clinical presentation described as ovarioleukodystrophy. We present a sibling pair: one with cerebellar ataxia and one with vision loss and cognitive impairment in addition to ataxia. Neither shows evidence of leukoencephalopathy on MRI imaging. Exome sequencing revealed that both siblings are compound heterozygous for AARS2 variants (p.Phe131del and p.Ile328Met). Yeast complementation assays indicate that p.Phe131del AARS2 dramatically impairs gene function and that p.Ile328Met AARS2 is a hypomorphic allele. This work expands the phenotypic spectrum of AARS2-associated disease to include ataxia without leukoencephalopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available